The estimated Net Worth of Kevin C Johnson is at least $4.43 Million dollars as of 22 December 2021. Mr. Johnson owns over 3,334 units of Neogenomics stock worth over $609,961 and over the last 11 years he sold NEO stock worth over $3,652,651. In addition, he makes $167,554 as Independent Director at Neogenomics.
Kevin has made over 10 trades of the Neogenomics stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 3,334 units of NEO stock worth $24,238 on 22 December 2021.
The largest trade he's ever made was selling 66,007 units of Neogenomics stock on 9 November 2018 worth over $1,124,099. On average, Kevin trades about 13,278 units every 112 days since 2014. As of 22 December 2021 he still owns at least 37,398 units of Neogenomics stock.
You can see the complete history of Mr. Johnson stock trades at the bottom of the page.
Kevin C. Johnson serves as Independent Director of the Company. Mr. Johnson has served as a director since October 2010. Mr. Johnson was the Chief Executive Officer for United Allergy Services, a provider of allergy testing and immunotherapy services, from September 2014 through July 2015. From January 2003 until September 2014 Mr. Johnson was retired. From May 1996 until January 2003, Mr. Johnson was Chairman, Chief Executive Officer and President of DIANON Systems, Inc. (“DIANON”), a publicly-traded cancer diagnostic services company providing anatomic pathology and molecular genetic testing services to physicians nationwide. During that time, DIANON grew annual revenues from approximately $56 million in 1996 to approximately $200 million in 2002. DIANON was sold to Laboratory Corporation of America (NYSE: LH) in January of 2003. Prior to joining DIANON in 1996, Mr. Johnson was employed by Quest Diagnostics and Quest’s predecessor, the Life Sciences Division of Corning, for 18 years, and held numerous management and executive level positions.
As the Independent Director of Neogenomics, the total compensation of Kevin Johnson at Neogenomics is $167,554. There are 13 executives at Neogenomics getting paid more, with Douglas VanOort having the highest compensation of $3,648,730.
Kevin Johnson is 65, he's been the Independent Director of Neogenomics since 2010. There are 2 older and 24 younger executives at Neogenomics. The oldest executive at Neogenomics Inc. is Raymond Hipp, 77, who is the Independent Director.
Kevin's mailing address filed with the SEC is 9490 NEOGENOMICS WAY, , FORT MYERS, FL, 33912.
Over the last 12 years, insiders at Neogenomics have traded over $310,374,253 worth of Neogenomics stock and bought 167,456 units worth $1,699,153 . The most active insiders traders include Electric Coge Medical Syste..., Oort Douglas M Van und Steven C Jones. On average, Neogenomics executives and independent directors trade stock every 23 days with the average trade being worth of $2,654,175. The most recent stock trade was executed by Alicia C Olivo on 15 August 2024, trading 1,040 units of NEO stock currently worth $16,692.
neogenomics laboratories is a leading cancer diagnostic reference laboratory that has provided high-quality cancer testing and partnership programs to pathologists and oncologists for over 10 years. we work every day to achieve our common purpose of saving lives by improving patient care through communication, accuracy, reliability, and efficiency. our areas of expertise include cancer cytogenetics with industry-leading turnaround times; hematologic and solid tumor fish testing with the largest menu of technical-only services available; 10-color flow cytometry; ihc supported by an extensive antibody library; and over 100 molecular oncology tests comprising the most comprehensive combination of multiparameter profiles and targeted biomarker tests in the industry. our technical-only testing programs feature on-demand or live training and are available to pathologists who wish to sign out fish, flow cytometry, and/or ihc. neogenomics’ extremely fast test development cycle means we are hig
Neogenomics executives and other stock owners filed with the SEC include: